- Sponsorship Agreement Promotes International Medical Education, Helps
Break Down Language Barrier -
WASHINGTON, Aug. 1 /PRNewswire/ -- Russian-speaking medical professionals around the world have a potent new ally to help them integrate into the English-speaking mainstream of global medical research.
Dr. Peter M. Leitner, President of MaxWell USA, LLC, and Dr. Marina Filshtinsky, President of Boston-based International Medical Information Technologies, Inc. (IMIT) and editor-in-chief of MedMir.com, announced today a sponsorship deal between their two organizations.
MaxWell USA will provide the first significant outside funding received by IMIT since its 2005 inception. As a result, IMIT will be in a stronger position to supply timely, comprehensive, and free translations of leading medical journal articles to Russian-speaking medical professionals around the world.
By partnering, MaxWell and IMIT will contribute more effectively to improving the quality of healthcare offered by Russian-speaking medical providers to their patients wherever they may be.
MedMir.com (http://www.medmir.com) is the first project of the Boston-based nonprofit organization International Medical Information Technologies, Inc., IMIT (http://www.imithome.org). MedMir provides Russian-speaking medical professionals around the world with free access to timely, comprehensive, and accurate summaries of leading research papers from the world's top medical journals, translated by highly qualified medical specialists. The MedMir project began in January 2005 and has consistently attracted a growing number of Russian-speaking medical professional visitors to its website. MedMir is the only service on the Internet that provides timely, comprehensive international medical information in Russian. MedMir.com = World Medical Journal Reviews In Russian.
MaxWell Biocorporation (http://www.max-well.com) is a U.S.-based,
privately-held international medical and pharmaceutical company with wholly
owned subsidiaries and affiliates in the United States and Ukraine
dedicated to increasing life expectancy and improving the quality of life
of people in Ukraine and other underserved emerging healthcare markets in
the former Soviet Union. MaxWell targets oncological, cardiological,
chronic infectious and autoimmune disorders and diseases through the
development, production, and introduction into clinical practice of
sophisticated, high quality, and affordable off-patent generic
biopharmaceutical and chemopharmaceutical medicines and the latest
diagnostic and therapeutic methods. MaxWell = "Maximum Wellness."
"We Help You Live Longer"
202-454-3403 Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Kenneth Alibek https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=78826 Peter Leitner https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=78827
|SOURCE MaxWell Biocorporation, LLC|
Copyright©2008 PR Newswire.
All rights reserved